Corpus Intelligence IC Memo — ADVENTHEALTH OTTAWA 2026-04-26 04:03 UTC
IC Memo — ADVENTHEALTH OTTAWA
Investment Committee Memorandum | KS | 36 beds | Grade D | EBITDA uplift $3.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ADVENTHEALTH OTTAWA

CCN 170014 | FRANKLIN, KS | 36 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

ADVENTHEALTH OTTAWA is a 36-bed community hospital in FRANKLIN, KS with $53.4M in net patient revenue and a -5.2% operating margin. The hospital serves a payer mix of 46.5% Medicare, 0.0% Medicaid, and 53.5% commercial.

Thesis: Turnaround. Our ML models identify $3.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -5.2% to 2.2% (+736bps).

Net Revenue HCRIS$53.4M
Current EBITDA COMPUTED$-2.7M
Operating Margin COMPUTED-5.2%
Occupancy HCRIS28.7%
Revenue / Bed COMPUTED$1.5M
Net-to-Gross HCRIS18.1%
Distress Probability MLnan%

2. Market Context & Competitive Position

152
KS Hospitals
-17.7%
State Median Margin
99
Comparable Hospitals

KS has 152 Medicare-certified hospitals with a median operating margin of -17.7%. The target's margin of -5.2% places it above the state median. Among 99 size-comparable peers (18-72 beds), the median margin is -19.1%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (18-72), prioritizing same-state peers. 99 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ADVENTHEALTH OTTAWA (Target)KS36$53.4M-5.2%
CHILDRENS MERCY HOSPITAL KANSAKS42$108.5M14.7%
VIA CHRISTI HOSPITAL PITTSBURGKS64$90.4M-16.9%
LABETTE COUNTY MEDICAL CENTERKS49$80.6M-14.3%
NEWMAN REGIONAL HEALTHKS23$73.9M-15.6%
KANSAS SPINE & SPECIALTY HOSPIKS35$69.6M19.1%
SOUTHWEST MEDICAL CENTERKS67$62.9M-22.9%
KANSAS SURGERY & RECOVERY CENTKS30$62.8M20.0%
KANSAS MEDICAL CENTERKS58$59.2M3.2%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.1M+210bp18mo
Cost to Collect4.5%2.5%$1.1M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.1M+198bp12mo
A/R Days Reduction5200.0%3800.0%$650K+122bp9mo
Clean Claim Rate88.0%96.0%$34K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.1M
Cost to Collect
$1.1M
Denial Rate Reduction
$1.1M
A/R Days Reduction
$650K
Clean Claim Rate
$34K
Total EBITDA Uplift$3.9M
Current EBITDA$-2.7M
+ RCM Uplift+$3.9M
Pro Forma EBITDA$1.2M
Current Margin-5.2%
Pro Forma Margin2.2%
WC Released (1x)$2.0M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-4.2M$21.2M0.00x-100.0%
Base (11x exit)10.0x11.0x$-4.2M$21.9M0.00x-100.0%
Bull Case9.0x11.0x$-3.8M$33.5M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-3.8M$35.4M0.00x-100.0%
Bear Case11.0x10.0x$-4.7M$2.9M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-4.7M$1.7M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 28.7%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 99 hospitals with 18-72 beds
  • Same-state prioritization (n=100)
  • Comp margins: P25=-30.6% / P50=-19.1% / P75=-8.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.